Bacterial products primarily mediate fibroblast inhibition in biomaterial infection

Journal of Surgical Research

Volumn 74, Issue 1, 1998, Pages 17-22

  Henke, Peter K ^a   Bergamini, Thomas M ^a,b   Watson, Andura L ^a   Brittian, Kenneth R ^b   Powell, David W ^b   Peyton, James C ^b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; DACRON; FORMALDEHYDE; INTERFERON; INTERLEUKIN 1ALPHA; POLITEF; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD VESSEL GRAFT; CELL PROLIFERATION; CONFERENCE PAPER; CONSERVATIVE TREATMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GRAFT INFECTION; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL ANALYSIS; WOUND HEALING;

EID: 0031814184     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5210     Document Type: Conference Paper

References (32)

1. Lorentzen J. E., Nielsen O. M., Arendrup H., Kimose H. H., Billie S., Andersen J. Vascular graft infection: An analysis of sixty two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery. 98:1985;81.
2. Mertens R. A., O'Hara P. J., Hertzer N. R., Krajewski L. P., Beven E. G. Surgical management of infrainguinal arterial prosthetic graft infections: Review of a thirty-five year experience. J. Vasc. Surg. 21:1995;782.
3. Calligaro K. D., Veith F. J., Schwartz M. L., Goldsmith J., Savarese R. P., Dougherty M. J., De Laurnetis D. A. Selective preservation of infected prosthetic arterial grafts: Analysis of a 20-year experience with 120 extracavity-infected grafts. Ann. Surg. 220:1994;461.
4. Padberg F. T., Smith S. M., Eng R. H. Accuracy of disincorporation for identification of vascular graft infection. Arch. Surg. 130:1995;183.
5. Bandyk D. F., Bergamini T. M., Kinney E. V., Seabrook G. R., Towne J. B. In situ replacement of vascular prostheses infected by bacterial biofilms. J. Vasc. Surg. 13:1991;575.
6. Towne J. B., Seabrook G. R., Bandyk D., Freischlag J. A., Edmiston C. E. In situ replacement of arterial prosthesis infected by bacterial biofilms: Long term follow-up. J. Vasc. Surg. 19:1994;226.
7. Kaebnick H. W., Bandyk D. F., Bergamini T. W., Towne J. B. The microbiology of explanted vascular prostheses. Surgery. 102:1987;756.
8. Barbul A. Immune aspects of wound repair. Clin. Plast. Surg. 17:1990;433.
9. Pricolo V. E., Caldwell M. D., Mastrofrancesco B., Mills C. D. Modulatory activities of wound fluid on fibroblast proliferation and collagen synthesis. J. Surg. Res. 48:1989;534.
10. Steenfos H. H., Hunt T. K., Scheuenstuhl H., Goodson W. H. Selective effects of tumor necrosis factor-alpha on wound healing in rats. Surgery. 106:1989;171.
11. Freundlich B., Bomalaski J. S., Neilson E., Jimenez S. A. Regulation of fibroblast proliferation and collegen synthesis by cytokines. Immunol. Today. 7:1986;303.
12. Hori T., Yamanaka Y., Hayakawa M., Shibamoto S., Tsujimoto M., Oku N., Fumiaka I. Prostaglandins antagonize fibroblast proliferation stimulated by tumor necrosis factor. Biochem. Biophys. Res. Commun. 174:1991;758.
13. Concannon M. J., Barrett B. B., Adelstein E. H., Thorton W. H., Puckett C. L. The inhibition of fibroblast proliferation by a novel monokine: An in vitro and in vivo study. J. Burn Care Rehabil. 14:1993;141.
14. Korn J. H., Halushka P. V., LeRoy E. C. Mononuclear cell modulation of connective tissue function: Suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J. Clin. Invest. 65:1980;543.
15. Postlethwaite A. E., Smith G. N., Mainardi C. L., Seyer J. M., Kang A. H. Lymphocyte modulation of fibroblast function in vitro: Stimulation and inhibition of collagen production by different effector molecules. J. Immunol. 132:1984;2470.
16. Ahrendt G. M., Tantry U. S., Barbul A. Intra-abdominal sepsis impairs colonic collagen synthesis. Am. J. Surg. 171:1996;102.
17. Henke, P. K. Bergamini, T. M. Brittian, K. R. Polk, H. C. Jr. Prostaglandin E2 modulates monocyte MHC-II suppression in biomaterial infection, J. Surg. Res.
18. 2. Infect. Immun. 62:1994;4160.
19. Timmerman C. P., Mattsson E., Martinez-Martinez L., De Graaf L., Van Strijp J. A., Verbrugh H. A., Verhoef J., Fleer A. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect. Immun. 61:1993;4167.
20. Heumann D., Barras C., Severin A., Glauser M. P., Tomasz A. Gram positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect. Immun. 62:1994;2715.
21. Goeau-Brissonniere O., Mercier F., Nicolas M. H., Bacourt F., Coggia M., Lebrault C., Pechere J. C. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed dacron graft. J. Vasc. Surg. 19:1994;739.
22. Morris G. E., Friend P. J., Vassallo D. J., Farrington M., Leapman S., Quick C. R. G. Antibiotic irrigation and conservative surgery of major aortic graft infection. J. Vasc. Surg. 20:1994;88.
23. Gristina A. G., Girdhar G., Gabriel B. L., Naylor P. T., Myrvik Q. N. Cell biology and mechanisms in artificial device infections. Int. J. Artif. Organs. 16:1993;755.
24. Chaudhary R., Simmons R. L. Pathogenesis of vascular graft infections. J. Vasc. Surg. 13:1991;755.
25. Johnson G. M., Lee D. A., Regelmann W. E., Gray E. D., Peters G., Quie P. G. Interference with granulocyte function by staphylococcus epidermidis slime. Infect. Immun. 54:1986;13.
26. Patrick C. C., Plaunt M. R., Hetherington S. V., May S. M. Role of the staphylococcal epidermidis slime layer in experimental tunnel tract infections. Infect. Immun. 60:1992;1363.
27. Kinnaert P., De Wilde J. P., Bournoville B., Husson C., Salmon I. Direct activation of human peritoneal mesothelial cells by heat killed microorganisms. Ann. Surg. 224:1996;749.
28. Morykwas M. J., Duell E. A., Jennings D. A., Ledbetter M. S., White W.L., Argenta L. C. Arachidonic acid metabolites: Effects on inflammation of fetal excisional wounds. Inflammation. 16:1992;251.
29. Martakos P., Karowski T. Healing characteristics of hybrid and conventional polytetrafluoroethylene vascular grafts. ASAIO J. 41:1995;M735.
30. Marois Y., Guidoin R., Roy R., Vidovsky T., Jakubiec B., Sigot-Luizard M. F., Braybrook J., Mehri T., Laroche G., King M. Selecting valid in vitro biocompatability tests that predict the in vivo healing response of synthetic vascular prostheses. Biomaterials. 17:1996;1835.
31. Ahn S., Williams D. E., Thye D. A., Cheng K. Q., Lee D. A. The isolation of a fibroblast growth inhibitor associated with perigraft seroma. J. Vasc. Surg. 20:1994;202.
32. Tsukayama D. T., Wicklund B., Gustilo R. B. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics. 14:1991;841.